All right, y'all. Money out of money in your Medicare for All right, y'all. Look, I wish I could tell you that I was declaring victory right about now.Turns out it takes a long time to count some votes in Michigan. It's a big state. But I will tell you this.I want you just to reflect on what that means. Right now, we are on track to vastly outvote the historical numbers that we should have expected. And that tells you about the kind of movement that we were able to inspire.A movement that kicked off 15 mont ...

Prices of lab monkeys in China have surged, complicating new drug development trials and increasing the need for primate imports from neighboring countries. https://t.co/ldF8bgRC7F📷️: Mladen Antonov/AFP/Getty Images https://t.co/tch2gujtqd ...

Shionogi CEO Pursues Drug Deals, Mulls Expanded US Production https://t.co/IDTIVCL791 ...

Novo Nordisk raised its forecast for the second time this year, citing higher expectations for its obesity and diabetes drug sales https://t.co/cJfQ0AC1DW ...

Hey, Kelly. So, yeah, Novo is now out with results earlier than expected. It was slated to report overnight just ahead of results from Eli Liy, but we now have Novo's full earnings release.So, Novo is raising its fullear guidance on both the top and bottom lines, not comparable to estimates due to being in constant currency, but the company is citing increased expectations for GLP1 product sales as the reason for the improved outlook. But Novo said it's expecting a sales decline within its US operations, wh ...

>> JUST INCHES AWAY FROM ALL-TIME HIGHS. 30 MINUTES UNTIL THE START OF YOUR CASH EQUITY TRADE. MICHAEL: BLOOMBERG OPEN INTEREST STARTS RIGHT NOW.DANI: COMING UP, ANOTHER RECORD IN SIGHT FOR THE S&P 500 AS A PACKED EARNINGS SLATE CATCHES RALLY. SPACEX STEPS INTO THE EARNINGS SPOTLIGHT WHILE OTHERWORLDLY DEMAND POWERS PALANTIR. IN OIL GIVES UP ITS GAINS AS HOPES RISE FOR A DIPLOMATIC BREAKTHROUGH BETWEEN THE.U.S.AND IRAN SOME OF THE STOCKS WE ARE WATCHING THIS MORNING, IT IS ABOUT EARNINGS AND THE AI TRADE. P ...

Best stocks in the market according to Josh Brown. Today spotlight >> shines on two biotechs. Tell us which ones.>> Yeah. Yeah. So uh we we p we published this uh yesterday and we wanted to do something that had nothing to do with data centers and GPUs and just take a break from that whole AI capex world that we've been living in for so long.Um, and we wanted to talk about stocks that are working away from that. And, uh, Insight is the first one we'll talk about. Not only is this name on the best stocks in ...

The Danish drugmaker said annual sales and operating profit should fall less than it previously expected following a boost in the second quarter. https://t.co/7wPq66Mr8N ...

The task ahead following America’s cuts to foreign aid is for researchers to make the best of the new reality. They have tools: in particular, a pipeline of promising drugs https://t.co/u3nYwg3NVN ...

Pfizer raised the midpoint of its 2026 sales forecast after reporting strong second-quarter demand for older medicines https://t.co/dQyR331CtS ...